Source: Annual Congress 2011 - Models of disease and drug actions
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Newton, E. King, C. Rider, C. Gwozd, N. Holden, J. Eddlestone, B. Zuraw, R. Leigh, P. O‘Byrne, M. Kelly (Calgary, Hamilton, Canada; La Jolla, United States Of America). Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells. Eur Respir J 2011; 38: Suppl. 55, 1773

Member's Comments

No comment yet.

Related content which might interest you: Proliferation is not increased in airway myofibroblasts isolated from asthmatics Source: Eur Respir J 2008; 32: 362-371 Year: 2008 Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004 A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018 Year: 2018 Caveolin-1 expression in airway smooth muscle cells is related to airway responsiveness magnitude in allergic asthma model Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003 Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Source: Eur Respir J 2007; 30: 653-661 Year: 2007 Decreased hyaluronan in airway smooth muscle cells of asthma and COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002 Corticosteroids and beta2-agonists modify hyaluronic acid homeostasis in human airway smooth muscle cells in asthma and COPD Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Corticosteroid insensitivity in airway smooth muscle cells of severe asthma and COPD: Modulation by IFN-γ Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function Source: Eur Respir J 2007; 30: Suppl. 51, 495s Year: 2007 Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012 Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004 Treating asthma means treating airway smooth muscle cells Source: Eur Respir J 2008; 32: 265-274 Year: 2008 The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC) Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011